IRIS
STELLA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.097
EU - Europa 1.132
AS - Asia 749
SA - Sud America 234
AF - Africa 186
OC - Oceania 1
Totale 4.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.050
IT - Italia 563
SG - Singapore 391
BR - Brasile 223
IE - Irlanda 219
CN - Cina 182
CI - Costa d'Avorio 113
IN - India 89
UA - Ucraina 80
DE - Germania 75
SN - Senegal 56
RU - Federazione Russa 44
CA - Canada 42
VN - Vietnam 35
BE - Belgio 22
SE - Svezia 22
FI - Finlandia 19
GB - Regno Unito 19
CZ - Repubblica Ceca 14
FR - Francia 13
TR - Turchia 9
NG - Nigeria 8
CH - Svizzera 7
NL - Olanda 7
IQ - Iraq 6
PL - Polonia 6
UZ - Uzbekistan 6
AR - Argentina 5
BD - Bangladesh 5
GR - Grecia 5
MA - Marocco 5
AT - Austria 4
ES - Italia 4
NO - Norvegia 4
EC - Ecuador 3
HK - Hong Kong 3
IL - Israele 3
IR - Iran 3
JP - Giappone 3
MX - Messico 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
KZ - Kazakistan 2
PY - Paraguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
GL - Groenlandia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LB - Libano 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.399
Salva come PNG Salva come JPEG
Città #
Santa Clara 505
Chandler 326
Singapore 249
Chicago 225
Dublin 219
Catania 137
Abidjan 113
Jacksonville 95
Boardman 84
Kochi 79
Cambridge 60
Ashburn 59
Lawrence 59
Dakar 56
Andover 55
Civitanova Marche 54
Grafing 35
Palermo 35
Nanjing 34
Des Moines 30
Wilmington 29
The Dalles 27
Dong Ket 26
Toronto 24
Brussels 22
Milan 21
Rome 19
Council Bluffs 17
Munich 17
Bari 15
Los Angeles 15
Brno 13
San Mateo 13
New York 12
Santa Venerina 12
Beijing 11
Jiaxing 11
Messina 11
Nanchang 11
Ottawa 11
São Paulo 11
Falls Church 10
Turku 10
Aci Catena 9
Bremen 9
Hanoi 9
Saint Petersburg 9
Seattle 9
Abuja 8
Belo Horizonte 8
Curitiba 8
Hanover 7
Hebei 7
Pune 7
Redmond 7
Hefei 6
Scottsdale 6
Fairfield 5
Florence 5
Giardini-Naxos 5
Helsinki 5
Mascalucia 5
San Giovanni la Punta 5
Shenyang 5
Brasília 4
Casablanca 4
Changsha 4
Comiso 4
Cosenza 4
Edinburgh 4
Fantina 4
Grammichele 4
Juiz de Fora 4
Lappeenranta 4
Manaus 4
Modica 4
Montreal 4
Redwood City 4
Siracusa 4
Arcugnano 3
Bedford 3
Belém 3
Catanzaro 3
Florianópolis 3
Frankfurt am Main 3
Guarulhos 3
Jinan 3
London 3
Marília 3
Moscow 3
Nicolosi 3
Oslo 3
Portland 3
Ribeirão Preto 3
Rio de Janeiro 3
Rometta 3
San Francisco 3
São Bernardo do Campo 3
Tokyo 3
Trecastagni 3
Totale 3.144
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 154
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 113
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 104
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 97
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 95
Biomarkers and prognostic factors for malignant pleural mesothelioma 91
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 89
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 86
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 86
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 86
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 85
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 84
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 82
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 82
New insights in thyroid cancer and p53 family proteins 81
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 80
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 80
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 79
Double-face activity of resveratrol in voluntary runners: assessment of DNA damage by comet assay. 78
Uncommon long-term survival in a patient with chronic myeloid leukemia 78
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 78
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 78
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 76
Rufloxacin induced photosensitization in bio-models of increasing complexity 73
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 73
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 72
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 72
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 70
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 70
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 70
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 69
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 68
Detection and clinical implications of a novel BCR-ABL1 E12A2 insertion/deletion in a CML patient expressing the E13A2 isoform 67
Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity 65
Opportunities and challenges of liquid biopsy in thyroid cancer 64
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 63
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 63
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 62
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 61
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors 59
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase 59
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 58
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 58
Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia 56
THE ROLE OF SPARC IN CHRONIC MYELOID LEUKEMIA 56
The Role of New Technologies in Myeloproliferative Neoplasms 56
Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma 56
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 54
High BCR-ABL/GUS(IS) Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib 54
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 54
Diagnosis of Chronic Myeloid Leukemia Early in Pregnancy 54
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients 53
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 52
Hyperdiploidy associated with a high BCR-ABL transcript level may identify patients at risk of progression in chronic myeloid leukemia 49
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia 49
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy 48
A case of high-risk AML in a patient with advanced systemic mastocytosis 46
Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis 45
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities 43
Approcci Terapeutici Innovativi per il Trattamento di Cellule di Leucemia Mieloide Cronica Resistenti ad Imatinib Mesilato 42
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 41
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 40
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes 40
Personalized strategies for CML patients considering discontinuation of tyrosine kinase inhibitors treatment 39
Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain 38
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 35
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 26
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 25
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 24
REThinking the role of the RET oncogene in breast cancer 20
A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis 20
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 5
Totale 4.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 0 19 42
2020/2021312 19 11 27 14 68 20 27 2 53 3 33 35
2021/2022435 20 67 11 7 78 8 64 15 25 11 30 99
2022/20231.036 68 82 56 119 58 148 13 201 209 14 46 22
2023/2024553 44 83 26 24 19 132 8 33 7 23 112 42
2024/20251.916 30 330 79 152 412 291 166 64 75 143 174 0
Totale 4.578